GSK Immatics team up for cancer cell therapies

GSK, Immatics team up for cancer cell therapies

Under the terms of the agreement, Immatics will receive an upfront payment of $45m.

Original Article: GSK, Immatics team up for cancer cell therapies

More From BioPortfolio on "GSK, Immatics team up for cancer cell therapies"